Serum glycoprotein hormone alpha sub-unit values and survival in metastatic melanoma patients.
Affiliation
Department of Endocrinology, Manchester University, Manchester M20 9BX, England.Issue Date
1979-12
Metadata
Show full item recordCitation
Serum glycoprotein hormone alpha sub-unit values and survival in metastatic melanoma patients. 1979, 15 (12):1497-501 Eur J CancerJournal
European Journal of CancerDOI
10.1016/0014-2964(79)90030-6PubMed ID
535613Type
ArticleLanguage
enISSN
0014-2964ae974a485f413a2113503eed53cd6c53
10.1016/0014-2964(79)90030-6
Scopus Count
Collections
Related articles
- Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.
- Authors: Ortega-Martínez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortés J, García-Vázquez MD, Pérez-Yarza G, Izu R, Luís Díaz-Ramón J, de la Fuente IM, Asumendi A, Boyano MD
- Issue date: 2016 Oct 1
- Elevated serum levels of S100 and survival in metastatic malignant melanoma.
- Authors: Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Wittke F, Hoffmann R, Ganser A, Atzpodien J
- Issue date: 1997
- Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
- Authors: Franzke A, Probst-Kepper M, Buer J, Duensing S, Hoffmann R, Wittke F, Volkenandt M, Ganser A, Atzpodien J
- Issue date: 1998 Jul
- A prognostic model and staging for metastatic uveal melanoma.
- Authors: Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä T
- Issue date: 2003 Jan 15
- Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.
- Authors: Phan GQ, Attia P, Steinberg SM, White DE, Rosenberg SA
- Issue date: 2001 Aug 1